{
    "organizations": [],
    "uuid": "a804cd786accd3f6af71b1ec1346070369f82a05",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-molmed-starts-collaboration-with-o/brief-molmed-starts-collaboration-with-orchard-therapeutics-for-rare-diseases-idUSFWN1RP0ED",
    "ord_in_thread": 0,
    "title": "BRIEF-MolMed Starts Collaboration With Orchard Therapeutics For Rare Diseases",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12 (Reuters) - Molecular Medicine SpA:\n* STARTS COLLABORATION WITH ORCHARD THERAPEUTICS ON GENE THERAPY FOR RARE DISEASES Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-12T16:14:00.000+03:00",
    "crawled": "2018-04-13T17:58:49.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "molecular",
        "medicine",
        "spa",
        "start",
        "collaboration",
        "orchard",
        "therapeutic",
        "gene",
        "therapy",
        "rare",
        "disease",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}